Carla R Jungquist1, Ann Quinlan-Colwell2, April Vallerand3, Heather L Carlisle4, Maureen Cooney5, Susan J Dempsey6, Danielle Dunwoody7, Angelika Maly3, Kathy Meloche8, Ashley Meyers9, Jason Sawyer10, Navdeep Singh3, Denise Sullivan11, Chris Watson12, Rosemary C Polomano13. 1. University at Buffalo, Buffalo, New York. Electronic address: Carlajun@Buffalo.edu. 2. Private Practice Pain Management Consulting and Education, Wilmington, North Carolina. 3. Wayne State University, Detroit, Michigan. 4. University of Arizona, Tucson, Arizona. 5. Westchester Medical Center, Valhalla, New York. 6. University of California, Los Angeles, Los Angeles, California. 7. Halton Healthcare, Oakville, Ontario, Canada. 8. Harper University Hospital, Detroit, Michigan. 9. Sparrow Hospital, DeWitt, Michigan. 10. Sunnybrook Health Sciences Centre, Toronto, Canada. 11. NYC Health+Hospitals/Jacobi, Bronx, New York. 12. East Alabama Medical Center, Opelika, Alabama. 13. University of Pennsylvania, Philadelphia, Pennsylvania.
Abstract
OBJECTIVES: This report presents up-to-date evidence and expert consensus-based revisions to the ASPMN 2011 guidelines that inform interprofessional clinical decision-making for hospitalized adults receiving opioid analgesics. DESIGN: Systematic review of the literature. METHODS: A 14-member expert panel was charged with reviewing and grading the strength of scientific evidence published in peer reviewed journals and revising the ASPMN 2011 existing guidelines. Panel members formulated recommendations based on the strength of evidence and reached consensus through discussion, reappraisal of evidence, and voting by majority when necessary. The American Society of Anesthesiologists evidence categories for grading and classifying the strength of the evidence were used. Recommendations were subjected to a critical review by ASPMN members as well as external reviews. RESULTS: The 2011 guidelines were found to still be relevant to clinical practice, but new evidence substantiated refinement and more specific recommendations for electronic monitoring. The revised guidelines present risk factors divided into three categories: patient-specific, treatment-related, and environment of care. Specific recommendations for the use of electronic monitoring are delineated. CONCLUSIONS: All hospitalized patients that are administered opioids for acute pain are at risk of opioid induced advancing sedation and respiratory depression, but some patients are at high risk and require extra vigilance to prevent adverse events. All patients must be assessed for level of risk. Adaptations to the plan of care and monitoring strategies should be driven by iterative re-assessments according to level of risk. NURSING PRACTICE IMPLICATIONS: Opioid medications continue to be a major component in the management of acute pain. Clinicians have the primary responsibility for safe and effective pain management. Evidence based monitoring strategies can improve patient safety with opioids.
OBJECTIVES: This report presents up-to-date evidence and expert consensus-based revisions to the ASPMN 2011 guidelines that inform interprofessional clinical decision-making for hospitalized adults receiving opioid analgesics. DESIGN: Systematic review of the literature. METHODS: A 14-member expert panel was charged with reviewing and grading the strength of scientific evidence published in peer reviewed journals and revising the ASPMN 2011 existing guidelines. Panel members formulated recommendations based on the strength of evidence and reached consensus through discussion, reappraisal of evidence, and voting by majority when necessary. The American Society of Anesthesiologists evidence categories for grading and classifying the strength of the evidence were used. Recommendations were subjected to a critical review by ASPMN members as well as external reviews. RESULTS: The 2011 guidelines were found to still be relevant to clinical practice, but new evidence substantiated refinement and more specific recommendations for electronic monitoring. The revised guidelines present risk factors divided into three categories: patient-specific, treatment-related, and environment of care. Specific recommendations for the use of electronic monitoring are delineated. CONCLUSIONS: All hospitalized patients that are administered opioids for acute pain are at risk of opioid induced advancing sedation and respiratory depression, but some patients are at high risk and require extra vigilance to prevent adverse events. All patients must be assessed for level of risk. Adaptations to the plan of care and monitoring strategies should be driven by iterative re-assessments according to level of risk. NURSING PRACTICE IMPLICATIONS: Opioid medications continue to be a major component in the management of acute pain. Clinicians have the primary responsibility for safe and effective pain management. Evidence based monitoring strategies can improve patient safety with opioids.
Authors: Patricia C Dykes; Mica Curtin-Bowen; Troy Li; Avery Pullman; Alexandra Businger; Stuart Lipsitz; Ania Syrowatka; Michael Sainlaire; Tien Thai; David W Bates Journal: AMIA Annu Symp Proc Date: 2022-02-21
Authors: Sara J Hyland; Kara K Brockhaus; William R Vincent; Nicole Z Spence; Michelle M Lucki; Michael J Howkins; Robert K Cleary Journal: Healthcare (Basel) Date: 2021-03-16
Authors: John Garrett; Anneliese Vanston; Gerald Ogola; Briget da Graca; Cindy Cassity; Maria A Kouznetsova; Lauren R Hall; Taoran Qiu Journal: BMJ Open Date: 2021-11-24 Impact factor: 2.692